American Society for Microbiology, Journal of Clinical Microbiology, 5(59), 2021
DOI: 10.1128/jcm.03040-20
Full text: Unavailable
Helicobacter pylori infection is mainly diagnosed noninvasively, with susceptibility testing traditionally requiring endoscopy. Treatment is empirical, with clarithromycin-based triple therapy recommended where resistance rates are below 15%. Rising rates of clarithromycin resistance, resulting in high therapy failure rates, are seen worldwide, but U.S. data are limited.